Skip to content

A study to evaluate the efficacy of dwipanchmooladi tailam matra basti in the management of aamvata wsr to rheumatoid arthritis

An open labelled randomized controlled trial to evaluate the efficacy of dwipanchmooladi tailam matra basti , singhnad guggulu, baluka swedana in the management of aamvata w.s.r. to rheumatoid arthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081115
Enrollment
60
Registered
2025-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Institute for Ayurved Studies and Research Shri Krishna AYUSH University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to sign the consent form Patients between the age group of 30 to 60 years of either sex Both fresh and treated Patients presenting with clinical features of Aamvata mentioned in texts Assessment of Rheumatoid arthritis by assessment criteria ARA criteria and ACR and EULAR criteria Patients with chronicity of disease less than 5 years Patients fit for Basti Karma Anti CCP above normal range and or R A Factor above normal range and or ESR value should not exceeds 80 mg per dl and or CRP value above 1 mg per dl

Exclusion criteria

Exclusion criteria: Subjects with chronicity of disease more than 5 years Subjects of either sex age below 30 years and above 60 years The patients unfit for Basti Karma Patients having systemic pathologies like Cardiac disease and Hypertension Uncontrolled Diabetes Endocrine disorders TB of spine Spinal tumours Vertebral fractures Surgical conditions and Auto Immune disease like Ankylosing spondylitis Already diagnosed For both groups Rectal prolapse Fever Pregnant and Lactating mothers Patients with Renal and Hepatic impairment and requiring emergency treatment

Design outcomes

Primary

MeasureTime frame
The proportion of patients showing improvement in the level of Anti CCP post Basti KarmaTimepoint: 1st - 0 Day 2nd - After the completion of trial 3rd - On follow up

Secondary

MeasureTime frame
Reduction in R.A Factor level of the patient Reduction in ESR level of the patient Reduction in CRP level of the patient Assesment of Aamvata by clinical features given in Ayurvedic textbooks Assesment of Rheumatoid Arthritis by Subjective and Objective criteriaTimepoint: 1st - 0 Day 2nd - After the completion of trial 3rd - On follow up

Countries

India

Contacts

Public ContactPooja Rani

Institute for Ayurved Studies and Research

drashishhmehta@gmail.com8950375285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026